Drawing for CEIRAEON

USPTO serial 87886097

CEIRAEON

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KLUWE, CHERYL D
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CEIRAEON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Phi Lan M. Tinsley

PHI LAN M. TINSLEY K&L GATES LLPONE LINCOLN STREETSTATE STREET FINANCIAL CENTERBOSTON, MA 02111

Goods and services

ClassDescriptionStatusFirst use
010Wearable intra-ocular device in the nature of a medical device for monitoring a person's vital signs; computerized intra-ocular device in the nature of a medical device for monitoring vital signs and accessing and transmitting the data through the Internet; health monitoring device in the nature of wearable medical devices for individuals with health issues, namely, blood pressure monitors, thermometers, and pedometers with alert and monitoring capacity by means of telecommunication and global computer network; Wearable computerized intra-ocular device in the nature of a medical device for monitoring a person's vital signs; intra-ocular device for global positioning system in the nature of intra-ocular lens biometers also incorporating global positioning functionality; electromagnetic medical diagnostic imaging apparatus consisting of clean energy sources, gravitational control, vacuum fluctuations, and used to transmute electric fields using electromagnetic harnessing of plasma and other photonics apparatus, namely, laser diodes; apparatus for DNA testing for medical purposes, namely, apparatus for manipulation of DNA genotype and phenotype expression and treatment modalities and protocols utilizing computational and mathematical methodologies to identify and control molecular and atomic resonance frequencies utilizing the electromagnetic spectrumACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 6, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 6, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 3, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 17, 2019ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
May 9, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 9, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 9, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 20, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 6, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 4, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 28, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Feb 28, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 28, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 28, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 8, 2019DOCKASSIGNED TO EXAMINER—
Feb 8, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 8, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2019ALIEASSIGNED TO LIE—
Feb 1, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 28, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 10, 2018DOCKASSIGNED TO EXAMINER—
May 1, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 24, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance